Download PDF
1 / Pages

Other users also viewed these articles

Pneumocystis jirovecii in immunocompromised patients with rheumatic diseases Paloma Vela Casasempere; Paloma Ruiz Torregrosa; Raquel García Sevila;
Reumatol Clin. 2021;17:290-6
Recommendations by the Spanish Society of Rheumatology on risk management of biological treatment and JAK inhibitors in patients with rheumatoid arthritis Alejandro Balsa; Petra Díaz del Campo Fontecha; Lucía Silva Fernández; José Valencia Martín; Virginia Nistal Martínez; Fernando León Vázquez; M. Vanesa Hernández Hernández; Héctor Corominas; Rafael Cáliz Cáliz; José María Aguado García; Gloria Candelas Rodríguez; Nora Ibargoyen Roteta; Arturo Martí Carvajal; M. Nieves Plana Farras; Janet Puñal Riobóo; Hye Sang Park; Yolanda Triñanes Pego; Virginia Villaverde García;
Reumatol Clin. 2023;19:533-48
Reply to the Letter to the Editor from Drs Suárez-Diaz and Caminal-Montero in reference to the special article ¿Recommendations for prevention of infection in systemic autoimmune rheumatic diseases¿ Íñigo Rúa-Figueroa Fernández de Larrinoa; Patricia Carreira Delgado; Noé Brito García; Beatriz Tejera Segura; Julián de la Torre Cisneros;
Reumatol Clin. 2023;19:173